BioScrip Inc. (BIOS) had a rough trading day for Friday September 27 as shares tumbled 5.22%, or a loss of $-0.18 per share, to close at $3.27. After opening the day at $3.46, shares of BioScrip Inc. traded as high as $3.50 and as low as $3.27. Volume was 1.14 million shares over 5,646 trades, against an average daily volume of n/a shares and a total float of 703.09 million.
As a result of the decline, BioScrip Inc. now has a market cap of $2.3 billion. In the last year, shares of BioScrip Inc. have traded between a range of $4.14 and $1.56, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.
Option Care Health Inc formerly known as BioScrip Inc is one of the provider of home infusion services and home care management solutions in the United States. The firm’s home infusion services primarily involve the intravenous administration of medications treating a wide range of acute and chronic conditions, such as infections, nutritional deficiencies, various immunologic and neurologic disorders, cancer, pain and palliative care. It provides a wide array of home infusion products and services to meet the diverse needs of physicians, patients, and payors.
BioScrip Inc. is based out of Bannockburn, IL and has some 2,043 employees. Its CEO is John Charles Rademacher.